Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Key findings
Evolved xCas9 with expanded PAM recognition (NG, GAA, GAT). Increased targetable sites 4-fold while maintaining high specificity. Demonstrated phage-assisted continuous evolution methodology.